To check whether Brusatol affect FTL expression, western blot was used to check FTL-overexpression ESCC cell lines treated Brusatol after 0, 2, 4, 8, 24h for the recommended dose concentration (Fig. 7G). The gene discussed is FTL; the disease is esophageal squamous cell carcinoma.